Matches in Wikidata for { <http://www.wikidata.org/entity/Q66068544> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q66068544 description "clinical trial" @default.
- Q66068544 description "ensayu clínicu" @default.
- Q66068544 description "klinisch onderzoek" @default.
- Q66068544 description "клінічне випробування" @default.
- Q66068544 description "կլինիկական փորձարկում" @default.
- Q66068544 name "Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation" @default.
- Q66068544 name "Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation" @default.
- Q66068544 type Item @default.
- Q66068544 label "Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation" @default.
- Q66068544 label "Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation" @default.
- Q66068544 prefLabel "Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation" @default.
- Q66068544 prefLabel "Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation" @default.
- Q66068544 P1050 Q66068544-3175EB9B-1DD3-4038-B4BD-2ADB944201FF @default.
- Q66068544 P1050 Q66068544-32E9A519-3F91-4130-9663-D233A137D1F6 @default.
- Q66068544 P1050 Q66068544-43ED08DA-E92E-4096-BBFF-44542BE779F6 @default.
- Q66068544 P1132 Q66068544-ACAAD8FD-F89C-4F66-8AD6-E94EBDD95D58 @default.
- Q66068544 P1476 Q66068544-CA59C4B4-7F89-4AD4-8B3F-8069FE13512E @default.
- Q66068544 P17 Q66068544-589B738A-5A19-4471-AA18-2666B7D25CD9 @default.
- Q66068544 P3098 Q66068544-E404A149-9FA5-492D-A64C-8D7F519AA92B @default.
- Q66068544 P31 Q66068544-E949DB61-CBD7-45C4-B78E-C9E2E7B6C346 @default.
- Q66068544 P4844 Q66068544-48C73FED-2A9B-4872-A85E-461002C0190E @default.
- Q66068544 P4844 Q66068544-490B9A33-51DE-4F35-8206-BA95798FF002 @default.
- Q66068544 P580 Q66068544-53FCFA13-3B4A-4AB0-9E36-31E5CFC5159C @default.
- Q66068544 P582 Q66068544-344274EB-C670-4EFE-9D5C-908BE23BC304 @default.
- Q66068544 P6099 Q66068544-F7236713-3C12-43B4-A245-59EC3B13E530 @default.
- Q66068544 P6153 Q66068544-6B765466-62F1-4EDD-B0B1-1E002EF0C7EC @default.
- Q66068544 P8363 Q66068544-16F397EF-85A2-4F22-B2DC-057670192E5A @default.
- Q66068544 P1050 Q208414 @default.
- Q66068544 P1050 Q29496 @default.
- Q66068544 P1050 Q467635 @default.
- Q66068544 P1132 "+160" @default.
- Q66068544 P1476 "A Randomized Phase II Study to Compare the Net Clinical Benefit of Cyclosporine and Sirolimus Combined With MMF or Post-Transplant Cyclophosphamide as GVHD Prophylaxis After HLA-Matched or HLA-Mismatched Unrelated G-CSF Mobilized Blood Cell Transplantation Using Nonmyeloablative or Reduced Intensity Conditioning for Patients With Hematologic Malignancies: A Multi-Center Trial" @default.
- Q66068544 P17 Q30 @default.
- Q66068544 P3098 "NCT03246906" @default.
- Q66068544 P31 Q30612 @default.
- Q66068544 P4844 Q32089 @default.
- Q66068544 P4844 Q408524 @default.
- Q66068544 P580 "2017-09-11T00:00:00Z" @default.
- Q66068544 P582 "2022-08-15T00:00:00Z" @default.
- Q66068544 P6099 Q42824440 @default.
- Q66068544 P6153 Q219563 @default.
- Q66068544 P8363 Q78089383 @default.